| 摘要 |
FIELD: medicine, polypeptides. SUBSTANCE: invention relates to HCV- immunoreactive polypeptide compositions and involves nucleic acid molecules encoding immunoreactive polypeptides comprising viral epitopes of hepatitis type C. Advantage of invention involves creation of polypeptide compositions showing immunologically active cross reactions with many isolates of HCV, especially relative to heterogeneous domains of virus. EFFECT: valuable immune properties of polypeptides. 5 cl, 9 dwg, 6 tbl, 7 ex
|
